Businessweek Archives

Fda Be Nimble, Fda Be Quick


Washington Outlook: CAPITAL WRAPUP

FDA BE NIMBLE, FDA BE QUICK

Congress is finally moving to reform the Food & Drug Administration--cautiously. Senator Nancy L. Kassebaum (R-Kan.) is circulating a bill that would speed up FDA reviews of drugs and medical devices. One proposed change: allowing product approvals after one major clinical trial, instead of the current two. GOP hard-liners and some industry execs favor more radical deregulation. But companies are pleased that even modest FDA reform is under way at last.


Soul Searcher
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus